The public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.Send comments regarding this burden estimate or any other aspect of this collection of information, including suggesstions for reducing this burden, to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington VA, 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any oenalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
a. REPORTNew Therapeutic Strategies for Antibiotic-Resistant Select Agents 14. ABSTRACT
SECURITY CLASSIFICATION OF:The goal of this project was to establish the scientific basis for a new class of antibiotics that are needed to combat the development of resistance to currently available medications or the engineering of resistance into biological select agents. A multidisciplinary team of microbiologists, biochemists, molecular biologists and drug discovery experts was established to explore the hypothesis that disruption of bacterial primase activity will provide the basis for antimicrobial discovery and further, that the modular components of primase will provide for the discovery of broad-and narrow-spectrum antibiotics. The experimental model examined the functional activities of the Gram positive Staphylococcus aureus with the Gram negative E. S
REPORT DATE (DD-MM-YYYY)
TITLE AND SUBTITLE
31-12-200713. SUPPLEMENTARY NOTES The views, opinions and/or findings contained in this report are those of the author(s) and should not contrued as an official Department of the Army position, policy or decision, unless so designated by other documentation. Approved for public release; Federal purpose rights
UL
New Therapeutic Strategies for Antibiotic-Resistant Select AgentsReport Title
ABSTRACTThe goal of this project was to establish the scientific basis for a new class of antibiotics that are needed to combat the development of resistance to currently available medications or the engineering of resistance into biological select agents. A multidisciplinary team of microbiologists, biochemists, molecular biologists and drug discovery experts was established to explore the hypothesis that disruption of bacterial primase activity will provide the basis for antimicrobial discovery and further, that the modular components of primase will provide for the discovery of broad-and narrow-spectrum antibiotics. The experimental model examined the functional activities of the Gram positive Staphylococcus aureus with the Gram negative E. coli for purposes of establishing a protocol for extension to select agents including Bacillus anthracis and Yersinia pestis. Impo...